Literature DB >> 6561197

Angiotensin is not required for hypoxic constriction in salt solution-perfused rat lungs.

I F McMurtry.   

Abstract

It has been reported that angiotensin II is specifically required for hypoxic vasoconstriction in rat lungs perfused with physiological salt solution. However, studies with other preparations indicate that angiotensin II does not play a necessary role in the mechanism of hypoxic vasoconstriction. In an attempt to resolve this disagreement I investigated in salt solution-perfused rat lungs whether vasoactive agents other than angiotensin II would induce hypoxic vasoconstriction, and, if so, whether the effect was due to selective action on the hypoxic mechanism or to a nonspecific increase in vascular reactivity. The results showed the development of hypoxic pressor responses after addition to perfusate of plasma, angiotensin II, KCl, vanadate, 4-aminopyridine, or norepinephrine plus propranolol. In contrast, addition of saline (control), ouabain, or tetraethylammonium chloride did not induce hypoxic vasoconstriction. Saralasin inhibited the effect of angiotensin II, but not that of plasma. Induction of responsiveness to hypoxia was associated with an increase in normoxic perfusion pressure and with potentiation of pressor responses to KCl. These results suggest that angiotensin II does not play a unique, integral role in the hypoxic mechanism, but instead is only one of many substances that will induce hypoxic pressor reactivity by reversing the vascular hyporeactivity of salt solution-perfused rat lungs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6561197     DOI: 10.1152/jappl.1984.56.2.375

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  18 in total

Review 1.  Hypoxic pulmonary vasoconstriction: mechanisms and controversies.

Authors:  Philip I Aaronson; Tom P Robertson; Gregory A Knock; Silke Becker; Tristan H Lewis; Vladimir Snetkov; Jeremy P T Ward
Journal:  J Physiol       Date:  2005-10-27       Impact factor: 5.182

2.  The role of leukotrienes in acute hypoxic pulmonary vasoconstriction in rats.

Authors:  S R Li; D X Wang
Journal:  J Tongji Med Univ       Date:  1986

Review 3.  Hypoxia and the pulmonary circulation.

Authors:  I S Anand
Journal:  Thorax       Date:  1994       Impact factor: 9.139

4.  Superoxide generated at mitochondrial complex III triggers acute responses to hypoxia in the pulmonary circulation.

Authors:  Gregory B Waypa; Jeremy D Marks; Robert D Guzy; Paul T Mungai; Jacqueline M Schriewer; Danijela Dokic; Molly K Ball; Paul T Schumacker
Journal:  Am J Respir Crit Care Med       Date:  2013-01-17       Impact factor: 21.405

5.  Peroxiredoxin-5 targeted to the mitochondrial intermembrane space attenuates hypoxia-induced reactive oxygen species signalling.

Authors:  Simran S Sabharwal; Gregory B Waypa; Jeremy D Marks; Paul T Schumacker
Journal:  Biochem J       Date:  2013-12-15       Impact factor: 3.857

6.  Comparison of the effects of nicorandil, pinacidil and nitroglycerin on hypoxic and hypercapnic pulmonary vasoconstriction in the isolated perfused lung of rat.

Authors:  M Dumas; J P Dumas; L Rochette; C Advenier; J F Giudicelli
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

7.  Recurrent episodes of gram-negative bacteremia or endotoxemia change reactivity of pre- and post-capillary pulmonary segments to angiotensin or free radicals.

Authors:  O C Kirton; R G Gore; L M Reid; R C Jones
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

8.  Hypoxic pulmonary vasoconstriction in the absence of pretone: essential role for intracellular Ca2+ release.

Authors:  Michelle J Connolly; Jesus Prieto-Lloret; Silke Becker; Jeremy P T Ward; Philip I Aaronson
Journal:  J Physiol       Date:  2013-06-17       Impact factor: 5.182

Review 9.  Lung Circulation.

Authors:  Karthik Suresh; Larissa A Shimoda
Journal:  Compr Physiol       Date:  2016-03-15       Impact factor: 9.090

Review 10.  The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature.

Authors:  R I Cargill; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.